Phase I Study of the Combination of Afatinib and Ruxolitinib in Patients With Treatment-refractory Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to NSCLC
Related studies linked through entity extraction aliases.
Erlotinib 100mg or 150mg in Treating EGFR Mutated NSCLC
- Status
- UNKNOWN
- Phase
- PHASE3
Registry Measuring the Impact of Adding RNA Expression Testing on Referral Decisions in Early Stage Lung Cancer Patients and Assessing the Disease-free Survival With Long-term Follow-up
- Status
- TERMINATED
- Phase
- N/A
Registry Measuring Impact of RNA Expression Testing on Treatment Decisions in Early Stage Lung Cancer and Assessing the Disease-free Survival With Long-term Follow-up (ONC006)
- Status
- TERMINATED
- Phase
- N/A
A Study to Assess the Efficacy and Safety of the VEGFR-FGFR Inhibitor, Lucitanib, Given to Patients With Advanced/Metastatic Lung Cancer and FGF, VEGF, or PDGF Related Genetic Alterations
- Status
- TERMINATED
- Phase
- PHASE2
Dose Finding Study Of PF-05212384 With Paclitaxel And Carboplatin In Patients With Advanced Solid Tumor
- Status
- COMPLETED
- Phase
- PHASE1
Photon Versus Particle Therapy for Recurrent Lung Cancer; a Planning Study Based on a Reference Dataset of Patients.
- Status
- COMPLETED
- Phase
- N/A
A Phase 1b Study of MEDI4736 in Combination With Tremelimumab in Subjects With Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Circulating Fibrocytes in Non-small Cell Lung Cancer.
- Status
- UNKNOWN
- Phase
- N/A
Evaluation of the High Dose of Icotinib in Advanced Lung Cancer Patients After Failure of Target Therapy
- Status
- UNKNOWN
- Phase
- PHASE2
ATOM_local Ablative Therapy
- Status
- COMPLETED
- Phase
- PHASE2
An Open Label Study of BIBW 2992/Afatinib in Advanced Non-Small Cell Lung Cancer Patients Pre-treated With Erlotinib or Gefitinib
- Status
- UNKNOWN
- Phase
- PHASE2
Combination of Metformin With Gefitinib to Treat NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Afatinib Plus Nimotuzumb for NSCLC
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Lung HeXeRT: Helium, Xenon MRI for NSCLC Patients
- Status
- COMPLETED
- Phase
- N/A
Cabazitaxel in Relapsed and Metastatic NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection
- Status
- TERMINATED
- Phase
- PHASE1
Combination of gp96-Ig Vaccine, Theophylline and Oxygen for the Treatment of Patients With Advanced, Relapsed or Metastatic Non-Small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Safety of LEAD Radiotherapy Plus Chemoradiation in Patients With Bulky Stage III Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- NA